STADOL Drug Patent Profile

✉ Email this page to a colleague

When do Stadol patents expire, and when can generic versions of Stadol launch?

Stadol is a drug marketed by Apothecon and Bristol Myers Squibb and is included in two NDAs.

The generic ingredient in STADOL is butorphanol tartrate. There are eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the butorphanol tartrate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Stadol

A generic version of STADOL was approved as butorphanol tartrate by HIKMA on August 12^th, 1998.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for STADOL?
What are the global sales for STADOL?
What is Average Wholesale Price for STADOL?

Summary for STADOL

US Patents:	0
Applicants:	2
NDAs:	2
Raw Ingredient (Bulk) Api Vendors:	16
Patent Applications:	1,443
DailyMed Link:	STADOL at DailyMed

Drug patent expirations by year for STADOL

US Patents and Regulatory Information for STADOL

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Apothecon	STADOL	butorphanol tartrate	INJECTABLE;INJECTION	017857-004	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Apothecon	STADOL PRESERVATIVE FREE	butorphanol tartrate	INJECTABLE;INJECTION	017857-002	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Bristol Myers Squibb	STADOL	butorphanol tartrate	SPRAY, METERED;NASAL	019890-001	Dec 12, 1991		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Apothecon	STADOL PRESERVATIVE FREE	butorphanol tartrate	INJECTABLE;INJECTION	017857-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for STADOL

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bristol Myers Squibb	STADOL	butorphanol tartrate	SPRAY, METERED;NASAL	019890-001	Dec 12, 1991	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for STADOL

See the table below for patents covering STADOL around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Denmark	141624		⤷ Sign Up
Denmark	142620		⤷ Sign Up
Netherlands	7212176		⤷ Sign Up
Sweden	403286	MELLANPRODUKTER FOR FRAMSTELLNING AV 1,4-HYDROXIMORFINANDERIVAT	⤷ Sign Up
Hong Kong	2679	3-SUBSTITUTED-MORPHINAN DERIVATIVES	⤷ Sign Up
Yugoslavia	45099		⤷ Sign Up
Ireland	36688	3-SUBSTITUTED-MORPHINAN DERIVATIVES	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for STADOL

Make Better Decisions: Try a trial or see plans & pricing